Not for use in humans. Keep this and all drugs out of the reach of children.
Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention.
Prior to administration of INTERCEPTOR PLUS, dogs should be tested for existing heartworm infections. At the discretion of the veterinarian, infected dogs should be treated to remove adult heartworms. INTERCEPTOR PLUS is not effective against adult D. immitis.
Mild, transient hypersensitivity reactions, such as labored breathing, vomiting, hypersalivation, and lethargy, have been noted in some dogs treated with milbemycin oxime carrying a high number of circulating microfilariae. These reactions are presumably caused by release of protein from dead or dying microfilariae.
Do not use in puppies less than six weeks of age.
Do not use in dogs or puppies less than two pounds of body weight.
The safety of INTERCEPTOR PLUS has not been evaluated in dogs used for breeding or in lactating females. Studies have been performed with milbemycin oxime alone.
If a dose is missed by 15-30 days, heartworm prevention can be maintained if treated immediately and monthly dosing resumes for at least the next 2 months.
If a dose is missed by greater than 60 days, dosing may be recommenced and a blood test for adult heartworm must be performed after 6 months. Prior to administration of Interceptor Plus, dogs should be tested for existing heartworm infections.
Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.